| spelling |
oapen-20.500.12657-764652024-03-28T09:48:00Z Terrorism and the Pandemic Gunaratna, Rohan Petho-Kiss, Katalin Political Science Terrorism Social Science Violence In Society Anthropology Cultural & Social Coronavirus, known officially as SARS-CoV-2 (COVID-19), is an evolving threat. Threat entities have explored and exploited the pandemic to advance their agenda. Although lockdowns inhibited virus attacks in government-controlled areas, terrorist attacks continued unabated in the conflict areas. While government entities and military forces abided by lockdown measures, postponing training and scaling down operations, insurgent and terrorist groups operated relatively freely and mounted attacks. Both on the battlefields and off the battlefields, threat groups have invested in digital acceleration, maintaining strength and ideological influence during COVID-19. 2023-09-28T05:30:27Z 2023-09-28T05:30:27Z 2023 book 9781800738010 https://library.oapen.org/handle/20.500.12657/76465 eng application/pdf Attribution-NonCommercial-NoDerivatives 4.0 International external_content.pdf Berghahn Books Berghahn Books 10.3167/9781800738010 9043ff3b-22ff-4162-9c70-891297b93b9b 10.3167/9781800738010 562fcfcf-0356-4c23-869a-acb39d8c84b5 b818ba9d-2dd9-4fd7-a364-7f305aef7ee9 9781800738010 Knowledge Unlatched (KU) Berghahn Books Knowledge Unlatched open access
|
| description |
Coronavirus, known officially as SARS-CoV-2 (COVID-19), is an evolving threat. Threat entities have explored and exploited the pandemic to advance their agenda. Although lockdowns inhibited virus attacks in government-controlled areas, terrorist attacks continued unabated in the conflict areas. While government entities and military forces abided by lockdown measures, postponing training and scaling down operations, insurgent and terrorist groups operated relatively freely and mounted attacks. Both on the battlefields and off the battlefields, threat groups have invested in digital acceleration, maintaining strength and ideological influence during COVID-19.
|
